STOK — STOKE THERAPEUTICS INC

Ownership history in BVF INC/IL  ·  2 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in STOKE THERAPEUTICS INC (STOK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.42% (2025 Q4)
Avg. % of fund
2.0%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 2,265,674 +608,578 +36.7% 2.42% $71.9M $31.74
2025 Q3 INITIATED 1,657,096 — — 1.58% $38.9M $23.50
% of Fund (quarterly)    STOK price (monthly, adj. close)

Other funds also holding STOK

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 34.73% Redmile Group, LLC 3Y 7Y 9.43% Birchview Capital, LP 3Y 7Y 4.83% Opaleye Management Inc. 3Y 7Y 2.91% MPM BioImpact LLC 3Y 2.8% Siren, L.L.C. 2.13% RTW INVESTMENTS, LP 3Y 7Y 1.76% Quantedge Capital Pte Ltd 3Y 1.32% Parkman Healthcare Partners LLC 3Y 1.3% HighVista Strategies LLC 3Y 7Y 0.94%
← Back to BVF INC/IL Holdings